Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney
- PMID: 20571278
- PMCID: PMC2914374
- DOI: 10.1159/000316700
Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney
Abstract
Background/aim: It is well accepted that high dietary salt intake accelerates both hypertension and target organ damage. We have previously shown that eplerenone attenuates sustained elevated systolic blood pressure in Dahl salt-sensitive (SS) rats. In the present study, we investigated the role of eplerenone on vascular endothelial growth factor (VEGF) expression because we suspected that eplerenone treatment may trigger a unique mechanism that relies on the downregulation of VEGF.
Methods: Dahl SS rats were fed a high salt (8% NaCl) diet for 3 weeks and then switched to normal salt (0.3% NaCl) diet with or without treatment with eplerenone (100 mg/kg/day), enalapril (30 mg/kg/day) and their combination for an additional 3 weeks.
Results: In addition to reducing blood pressure, eplerenone inhibited glomeruli sclerosis and suppressed the expression of VEGF and endothelial nitric oxide synthase mRNA as well as protein levels.
Conclusions: Based on these findings, we suggest that in part, VEGF stimulation of endothelial nitric oxide synthase plays a significant role in the eplerenone-induced reversal of the renal and vascular damage caused by high dietary salt intake.
Copyright © 2010 S. Karger AG, Basel.
Figures


Similar articles
-
Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.Am J Physiol Renal Physiol. 2009 Sep;297(3):F802-8. doi: 10.1152/ajprenal.00197.2009. Epub 2009 Jun 17. Am J Physiol Renal Physiol. 2009. PMID: 19535572
-
Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.Nephrol Dial Transplant. 2010 Sep;25(9):2879-89. doi: 10.1093/ndt/gfq197. Epub 2010 Apr 20. Nephrol Dial Transplant. 2010. PMID: 20466668
-
Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension.Clin Exp Hypertens. 2011;33(8):538-47. doi: 10.3109/10641963.2011.566956. Epub 2011 Sep 27. Clin Exp Hypertens. 2011. PMID: 21950654 Free PMC article.
-
Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension.Hypertens Res. 2009 May;32(5):321-4. doi: 10.1038/hr.2009.29. Epub 2009 Mar 20. Hypertens Res. 2009. PMID: 19300447 Review.
-
Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.Heart Dis. 2003 Sep-Oct;5(5):354-63. doi: 10.1097/01.hdx.0000089783.30450.cb. Heart Dis. 2003. PMID: 14503934 Review.
Cited by
-
Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension.J Am Soc Nephrol. 2013 Jun;24(7):1053-62. doi: 10.1681/ASN.2012080839. Epub 2013 Apr 18. J Am Soc Nephrol. 2013. PMID: 23599382 Free PMC article.
-
Aldosterone Increases Vascular Permeability in Rat Skin.Cells. 2022 Aug 30;11(17):2707. doi: 10.3390/cells11172707. Cells. 2022. PMID: 36078114 Free PMC article.
References
-
- Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension. 2004;43:142–146. - PubMed
-
- Bayorh MA, Ganafa AA, Emmett N, Socci RR, Eatman D, Fridie IL. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension. Clin Exp Hypertens. 2005;4:355–367. - PubMed
-
- Cachofeiro V, Miana M, de Las Heras N, Martin-Fernandez B, Ballesteros S, Fernandez-Tresguerres J, Lahera V. Aldosterone and the vascular system. J Steroid Biochem Mol Biol. 2008;109:331–335. - PubMed
-
- Cortinovis M, Perico N, Cattaneo D, Remuzzi G. Aldosterone and progression of kidney disease. Ther Adv Cardiovasc Dis. 2009;3:133. - PubMed
-
- Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH, Adler GK. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension. 2002;39:614–618. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources